Phase I and II Clinicla Trials of Cancer Prevention Agents

癌症预防剂的 I 期和 II 期临床试验

• 批准号: 7695802
• 金额: $ 150万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7695802
• 关键词: Phase; II; Clinicla; Trials; Cancer

ARTICLE B.1. BRIEF DESCRIPTION OF SUPPLIES OR SERVICES The purpose of this procurement is to conduct multiple early phase (Phase 1 and Phase 2) clinical trials of the National Cancer Institute (NCI), Division of Cancer Prevention (DCP)-sponsored cancer preventive agents and to establish the infrastructures composed of one or more collaborating institutions that will perform these trials. The trials will assess the cancer preventive potential of various agents by evaluating the biologic effects of these agents on their molecular targets and by determining clinically relevant correlates.

第1条。耗材或服务的简要说明 该采购的目的是进行国家癌症研究所（NCI），预防癌症预防司（DCP）赞助的癌症预防药物的多个早期阶段（第1阶段和第2阶段），并建立由一个或多个协作机构组成的基础设施，这些机构将执行这些试验。这些试验将通过评估这些药物对它们的分子靶标的生物学作用以及确定临床相关的相关性来评估各种药物的癌症预防潜力。